Filter
989
Text search:
pharmaceutical
performance
Featured
95
301
Language
Document type
524
169
153
58
52
15
8
8
2
Countries
46
44
42
35
33
30
26
26
24
21
21
20
18
16
15
14
14
12
12
11
11
11
11
9
8
8
8
8
7
7
6
6
5
5
5
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
485
55
49
45
28
19
10
Toolboxes
91
70
66
56
44
34
21
20
20
17
16
15
15
14
14
14
6
5
5
5
5
4
2
1
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for
...
Mission report: June 11-20, 2017
A GUIDE FOR HEALTH WORKERS AND AUTHORITIES IN NIGERIA
DHS Further Analysis Reports No 102
Climate change is damaging human health now and is projected to have a greater impact in the future. Low- and middle-income countries are seeing the worst effects as they are most vulnerable to climate shifts and least able to adapt given weak health systems and poor infrastructure. Low-carbon appro
...
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. Cervical cancer is the
second most common cancer among women in South Africa, after breast cancer. Due
to limited access to prevention, early dia
...
Bridging the Gap
Global Campaign Against Epilepsy
Bulletin of the World Health Organization, 2001, 79 (4)
This course describes the health effects of war, weapons and strategies of violent conflict. Beginning with weapons of mass destruction it then moves on to other weapons and strategies of war such as the use of landmines and mass rape. The course concludes with a number of lessons which give an hist
...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima
...
"This document has been developed for outpatient oncology
facilities to serve as a model for a basic infection
control and prevention plan. It contains policies
and procedures tailored to these settings to meet minimal
expectations of patient protections as described
in the CDC Guide to Infecti
...
